LUM and cancer: Compound 91b1 dose-dependently downregulated the relative expression of Lumican in KYSE150 cells, suggesting that quinoline compound 91b1 probably induces an anticancer effect by downregulating the expression of Lumican, modulating its upstream or downstream signaling pathway in cancer cells.